Status:

TERMINATED

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Lead Sponsor:

FHI 360

Conditions:

HIV Infections

Eligibility:

MALE

18+ years

Phase:

PHASE2

Brief Summary

This Phase 2a study involving Tenofovir Disoproxil Fumarate (TDF) will provide extended safety data for high-risk men. Secondarily, the study will assess the feasibility of conducting the trial and ev...

Detailed Description

TDF has been selected for investigation as prophylaxis against HIV in high-risk men because of its unique pharmacologic profile. In addition to the convenience of being a once daily single tablet, TDF...

Eligibility Criteria

Inclusion

  • Be willing and able to give informed consent
  • Be 18 years or older
  • Be willing to use study product as directed
  • Be willing to adhere to follow-up schedule
  • Be willing to participate in the study for up to 12 months
  • Be in general good health (no active, serious infections that require parenteral antibiotics, no active clinically significant medical conditions, including heart disease, diabetes, asthma, alcoholism, and cancer)
  • Meet at least one of these three high risk criteria: \*Sex with sex worker/bar girl in last 3 months;
  • Sex with 2 or more women in last 3 months;
  • Sexually transmitted disease (STD) in last 3 months
  • Have absence of HIV antibodies by rapid test (at screening and enrollment visit)
  • Have absence of hepatitis B (HB) surface antigen (sAg)
  • Have adequate renal function (serum creatinine \<1.5 mg/dL)
  • Have adequate liver function (hepatic transaminases (ALT \<54 U/L and AST\<46 U/L)
  • Have adequate serum phosphorus (\>2.2 mg/dL)
  • Not be intending to relocate out of the area for the duration of the study participation and does not have a job or other obligations that may require long absences from the area
  • Not be receiving an experimental HIV vaccine

Exclusion

    Key Trial Info

    Start Date :

    Trial Type :

    INTERVENTIONAL

    End Date :

    Estimated Enrollment :

    500 Patients enrolled

    Trial Details

    Trial ID

    NCT00122512

    Last Update

    February 10 2006

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    UNC Project, Kamuzu Central Hospital

    Lilongwe, Malawi